Gilead Sciences Inc (GILD)
Current ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 19,173,000 | 16,085,000 | 15,227,000 | 15,056,000 | 15,816,000 |
| Total current liabilities | US$ in thousands | 12,004,000 | 11,280,000 | 11,237,000 | 11,610,000 | 11,397,000 |
| Current ratio | 1.60 | 1.43 | 1.36 | 1.30 | 1.39 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $19,173,000K ÷ $12,004,000K
= 1.60
The current ratio of Gilead Sciences Inc has been relatively stable over the past five years, ranging from 1.30 to 1.60. This indicates that the company has had a healthy level of current assets to cover its current liabilities during this period. A current ratio above 1 suggests that Gilead Sciences Inc has sufficient short-term assets to meet its short-term obligations. However, it is important to note that a very high current ratio could also indicate that the company is not efficiently utilizing its current assets. Overall, the trend of the current ratio for Gilead Sciences Inc reflects a generally positive liquidity position.
Peer comparison
Dec 31, 2024